60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.170
+0.020 (1.74%)
At close: Sep 25, 2026, 4:00 PM EDT
1.190
+0.020 (1.68%)
Pre-market: Sep 28, 2026, 8:25 AM EDT
SXTP Market Cap
SXTP has a market cap or net worth of $4.11 million as of September 25, 2026. Its market cap has decreased by -27.88% in one year.
Market Cap
4.11M
Enterprise Value
3.24M
1-Year Change
-27.88%
Ranking
Category
Stock Price
$1.17
ChartMarket Cap Chart
Since the IPO on July 12, 2023, SXTP's market cap has decreased from $29.52M to $4.11M, a decrease of -86.06%. That is a compound annual growth rate of -45.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 4.11M | 91.36% |
| Dec 31, 2025 | 2.15M | -27.44% |
| Dec 31, 2024 | 2.96M | -49.90% |
| Dec 29, 2023 | 5.92M | -79.96% |
| Jul 12, 2023 | 29.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaCyte Biotech | 4.73M |
| Dermata Therapeutics | 4.59M |
| GRI Bio | 4.48M |
| Calidi Biotherapeutics | 4.18M |
| Cadrenal Therapeutics | 4.10M |
| Onconetix | 4.07M |
| Propanc Biopharma | 3.99M |
| Lakewood-Amedex Biotherapeutics | 3.96M |